USANA Health Sciences, Inc.

NYSE:USNA Stock Report

Market Cap: US$928.7m

USANA Health Sciences Future Growth

Future criteria checks 0/6

USANA Health Sciences's revenue and earnings are forecast to decline at 0.02% and 3% per annum respectively. EPS is expected to decline by 3.1% per annum. Return on equity is forecast to be 10.3% in 3 years.

Key information

-3.0%

Earnings growth rate

-3.1%

EPS growth rate

Personal Products earnings growth23.8%
Revenue growth rate-0.02%
Future return on equity10.3%
Analyst coverage

Low

Last updated22 Feb 2024

Recent future growth updates

Recent updates

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Feb 08
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

Jan 06
Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

Oct 23

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Sep 09
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

Jul 27
Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

USANA Earnings Preview: From China's Challenge To India's Promise

Jul 21

USANA Health Sciences says Brown will transition to CEO in July 2023

Feb 13

Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

Feb 02
Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct 25

Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Oct 18
Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Jul 22
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Jul 07
Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Jun 14
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

May 31
Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside

Apr 28

Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future

Mar 05
Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future

USANA: 15x P/E, 14% Net Cash, Stock Repurchases

Feb 17

A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)

Jan 24
A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)

At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?

Jan 11
At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?

Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today

Nov 15
Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today

USANA: Q3 Mixed Results, We See 35% Upside, 15% 10-Year EPS CAGR

Oct 28

USANA: +42% EPS Growth, Upside Of 37%, Rapidly Growing In China Markets

Sep 29

Is Now An Opportune Moment To Examine USANA Health Sciences, Inc. (NYSE:USNA)?

Sep 28
Is Now An Opportune Moment To Examine USANA Health Sciences, Inc. (NYSE:USNA)?

Earnings and Revenue Growth Forecasts

NYSE:USNA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20259216070862
12/31/20248895361772
12/30/2023921645671N/A
9/30/2023928607585N/A
7/1/2023948637992N/A
4/1/2023974658697N/A
12/31/20229996994104N/A
10/1/20221,038777888N/A
7/2/20221,079898497N/A
4/2/20221,151108108121N/A
1/1/20221,186117108121N/A
10/2/20211,230136133144N/A
7/3/20211,254139148156N/A
4/3/20211,176129140149N/A
1/2/20211,135125145160N/A
9/26/20201,095116149168N/A
6/27/20201,058110149169N/A
3/28/20201,055103131152N/A
12/28/20191,061101110127N/A
9/28/20191,08910297111N/A
6/29/20191,125109104116N/A
3/30/20191,170121127138N/A
12/29/20181,189126141152N/A
9/29/20181,16388154167N/A
6/30/20181,12881112125N/A
3/31/20181,08470129141N/A
12/30/20171,04763111124N/A
9/30/20171,02790N/A124N/A
7/1/20171,02097N/A145N/A
4/1/20171,02199N/A125N/A
12/31/20161,006100N/A137N/A
10/1/2016986102N/A119N/A
7/2/201696598N/A113N/A
4/2/201694097N/A101N/A
1/2/201691895N/A111N/A
10/3/201591492N/A112N/A
7/4/201587286N/A120N/A
4/4/201582780N/A126N/A
1/3/201579077N/A105N/A
9/27/201474976N/A102N/A
6/28/201473173N/A83N/A
3/29/201473178N/A81N/A
12/28/201371879N/A99N/A
9/28/201370077N/A94N/A
6/29/201369278N/A96N/A
3/30/201366470N/A90N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: USNA's earnings are forecast to decline over the next 3 years (-3% per year).

Earnings vs Market: USNA's earnings are forecast to decline over the next 3 years (-3% per year).

High Growth Earnings: USNA's earnings are forecast to decline over the next 3 years.

Revenue vs Market: USNA's revenue is expected to decline over the next 3 years (-0.02% per year).

High Growth Revenue: USNA's revenue is forecast to decline over the next 3 years (-0.02% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: USNA's Return on Equity is forecast to be low in 3 years time (10.3%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.